AJJ Medtech Holdings (SGX:584) OCF Margin %: -56.99% (As of Mar. 2026)


What is AJJ Medtech Holdings OCF Margin %?

AJJ Medtech Holdings SGX:584 OCF Margin % is -56.99% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 818 Medical Devices & Instruments companies, AJJ Medtech Holdings ranks worse than 80.07% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. AJJ Medtech Holdings's Cash Flow from Operations for the three months ended in Mar. 2026 was S$-0.27 Mil. AJJ Medtech Holdings's Revenue for the three months ended in Mar. 2026 was S$0.47 Mil. Therefore, AJJ Medtech Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was -56.99%.

As of today, AJJ Medtech Holdings's current OCF Yield % is -18.06%.

The historical rank and industry rank for AJJ Medtech Holdings's OCF Margin % or its related term are showing as below:

SGX:584' s OCF Margin % Range Over the Past 10 Years
Min: -1737.93   Med: -109.58   Max: -0.43
Current: -46.13

During the past 13 years, the highest OCF Margin % of AJJ Medtech Holdings was -0.43%. The lowest was -1737.93%. And the median was -109.58%.

SGX:584's OCF Margin % is ranked worse than
80.07% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 5.785 vs SGX:584: -46.13

AJJ Medtech Holdings OCF Margin % Related Terms

AJJ Medtech Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for AJJ Medtech Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AJJ Medtech Holdings OCF Margin % Chart

AJJ Medtech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,737.93 -537.42 -107.74 -69.52 -35.81

AJJ Medtech Holdings Quarterly Data
Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.72 -9.23 -13.25 -89.90 -56.99

SGX:584 vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, AJJ Medtech Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AJJ Medtech Holdings OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AJJ Medtech Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where AJJ Medtech Holdings's OCF Margin % falls into.


AJJ Medtech Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

AJJ Medtech Holdings's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.143/3.192
=-35.81 %

AJJ Medtech Holdings's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.265/0.465
=-56.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -56.99% mean?
AJJ Medtech Holdings (SGX:584) has a OCF Margin % of -56.99% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AJJ Medtech Holdings and its competitors. According to the industry distribution chart, AJJ Medtech Holdings ranks #655 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 80.1%.
Is AJJ Medtech Holdings' OCF Margin % too high?
AJJ Medtech Holdings' current OCF Margin % is -56.99%. Based on the distribution chart, AJJ Medtech Holdings ranks #655 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does AJJ Medtech Holdings' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AJJ Medtech Holdings ranks #655 out of 818 companies for OCF Margin %. This places AJJ Medtech Holdings in the lower half of its industry. The industry median OCF Margin % is 5.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.79, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AJJ Medtech Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AJJ Medtech Holdings's current OCF Margin % is -56.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AJJ Medtech Holdings stock overvalued right now?
Based on GuruFocus' analysis, AJJ Medtech Holdings (SGX:584) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.01, compared to a current price of S$0.00 — trading 60% below its estimated fair value. The current OCF Margin % is -56.99%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For AJJ Medtech Holdings (SGX:584), the current OCF Margin % is -56.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AJJ Medtech Holdings Business Description

Address 8 Commonwealth Lane, No. 02-04, Grande Building, Singapore, SGP, 149555
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.